
Molecules (2020)
Update date:2022-08-03
Topics:
Burgess, Steven J.
Gunsaru, Bornface
Kelly, Jane X.
Li, Yuexin
Liebman, Katherine M.
Liebman, Michael C.
Morrill, Westin
Peyton, David H.
Quinoline-based scaffolds have been the mainstay of antimalarial drugs, including many artemisinin combination therapies (ACTs), over the history ofmoderndrugdevelopment. Althoughmuch progress has beenmade in the search for novel antimalarial scaffolds, itmay be that quinolineswill remain useful, especially if very potent compounds fromthis class are discovered. We report here the results of a structure-activity relationship(SAR) study assessingpotentialunsymmetrical bisquinoline antiplasmodial drug candidates using in vitro activity against intact parasites in cell culture. Many unsymmetrical bisquinolineswere found to be highly potent against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum parasites. Further work to develop such compounds could focus on minimizing toxicities in order to find suitable candidates for clinical evaluation.
View Morechengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Baoding City Light Industry And Textiles Imp.& Exp. Corp. Chemical Department.
Contact:86-312-3262436
Address:NO.658 CHAOYANG SOUTH STREET,BAODING CITY HEBEI CHINA
Nanjing Chemical Material Corp.(NCMC)
website:http://www.njchemm.com
Contact:0086-25-83172879
Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
website:http://www.antaibio.com
Contact:0086-21-65663057
Address:Room 2108, Building 2,No. 489 Zhengli Road,200433
Doi:10.1016/j.bmc.2005.04.078
(2005)Doi:10.1055/s-2005-869836
(2005)Doi:10.1021/jo00163a002
(1983)Doi:10.1016/S0040-4039(00)81401-X
(1983)Doi:10.1248/cpb.35.2388
(1987)Doi:10.1016/j.jorganchem.2005.04.007
(2005)